Evaluation of Insulinosecretion and Insulinosensitivity;Évaluation de l'insulinosécretion et de l'insulinosensibilité

Therapie

Volumn 62, Issue 4, 2007, Pages 311-318

  Scheen, André J ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Glucose; Insulin resistance; Insulin secretion; Methods; Modeling

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

BLOOD GLUCOSE MONITORING; CONFERENCE PAPER; DIAGNOSTIC TEST; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; ANIMAL; DRUG EFFECT; HOMEOSTASIS; INSULIN RESISTANCE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SECRETION;

ANIMALS; DIABETES MELLITUS, TYPE 2; GLUCOSE CLAMP TECHNIQUE; HOMEOSTASIS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE;

EID: 38449117940     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2007053     Document Type: Conference Paper

References (45)

1. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003; 46: 3-19
2. Scheen AJ. Le concept d'insulinosensibilité. Diabetes Metab 2001; 27: 193-200
3. Scheen AJ, Lefèbvre PJ. Insulin resistance versus insulin deficiency: which one comes first? The old question revisited. In: Di Mario U, Leonetti F, Pugliese G, Sbraccia P, Signore A, eds. Diabetes in the New Millennium. New York: Wiley & Sons, 2000: 101-13
4. Scheen AJ, Paquot N, Letiexhe M, et al. Glucose metabolism in obese subjects: lessons from OGTT, IVGTT, and clamp studies. Int J Obesity 1995; 19 (Suppl 3): S14-S20
5. American Diabetes Association. Consensus Development Conference on insulin resistance. Diabetes Care 1998; 21: 310-4
6. Krentz AJ, Bailey CJ. Oral antidiabetic agents. Current role in type 2 diabetes mellitus. Drugs 2005; 65: 385-411
7. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963-72 and Diabetologia 2006; 49: 1711-21
8. Scheen AJ, Lefèbvre PJ. Oral antidiabetic agents: a guide to selection. Drugs 1998; 55: 225-36
9. Polonsky KS, Rubenstein AH. Current approaches to measurement of insulin secretion. Diabetes Metab Rev 1986; 2: 315-29
10. Hovorka R, Jones RH. How to measure insulin secretion. Diabetes Metab Rev 1994; 10: 91-117
11. Scheen AJ, Paquot N, Letiexhe MR, et al. Comment évaluer la sécrétion insulinique en pratique ? Diabetes Metab 1995; 21: 458-64
12. Vague Ph, Nguyen L. Rationale and methods for the estimation of insulin secretion in a given patient. From research to clinical practice. Diabetes 2001; 51 (Suppl 1): S240-244
13. Scheen AJ. Evaluation de l'insulinosécrétion. In: Traité de Diabétologie. Ed: Grimaldi A, Médecine-Sciences Flammarion, Paris, France, 2005: 98-109
14. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-95
15. Polonsky K, Frank B, Pugh W, et al. The limitations to and valid use of C-peptide as a marker of the secretion of insulin. Diabetes 1986; 35: 379-86
16. Del Prato S, Tiengo A. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev 2001; 17: 164-74
17. Scheen AJ. Pathophysiology of insulin secretion. Ann Endocrinol (Paris) 2004; 65: 29-36
18. Scheen AJ, Castillo MJ, Lefèbvre PJ. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test. Methodological aspects and clinical applications. Diabete Metab 1996; 22: 397-406
19. Byrne MM, Sturis J, Polonsky KS. Insulin secretion and clearance during low-dose graded glucose infusion. Am J Physiol 1995; 268: E21-7
20. Bergman RN. Towards physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989; 38: 1512-27
21. Bergman RN, Ader M, Huecking K, et al. Accurate assessment of β-cell function. Diabetes 2002; 51 (Suppl. 1): S212-S220
22. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 232: E214-23
23. Mitrakou A, Vuorinen-Markkola H, Raptis G, et al. Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemic clamp. J Clin Endocrinol Metab 1992; 75: 379-82
24. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: 295-301
25. Luyckx FH, Scheen AJ. L'hyperglycémie provoquée par voie orale. Etude de la sécrétion, de la clairance et de l'action de l'insuline, et du rétrocontrôle par les hormones de la contre-régulation. Immunoanal Biol Spéc 2003; 18: 185-90
26. Mari A, Schmitz O, Gastaldelli A, et al. Meal and oral glucose tests for assessment of β cell function: modelling analysis in normal subjects. Am J Physiol Endocrinol Metab 2002; 283: E1159-66
27. Fritsche A, Stefan N, Hardt E, et al. A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility. Eur J Clin Invest 2000; 30: 411-8
28. Scheen AJ, Castillo MJ, Lefèbvre PJ. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement. Diab Metab 1996; 22: 455-8
29. Kjems LL, Christiansen E, Volund A, et al. Validation of methods for measurement of insulin secretion in humans in vivo. Diabetes 2000; 49: 580-8
30. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985; 6: 45-86
31. Scheen AJ, Castillo MJ, Paquot N, Lefèbvre PJ. How to measure insulin action in vivo? Diabetes Metab Rev 1994; 10: 151-88
32. Raynaud E, Brun J-F, Pérez-Martin A, et al. Evaluation in vivo de la sensibilité à l'insuline et applications cliniques. Ann Biol Clin 1998; 56: 407-16
33. Scheen AJ. Comment apprécier chez l'homme l'action de l'insuline en recherche et en pratique. Ann Endocrinol (Paris) 1999; 60: 179-87
34. Rabasa-Lhoret R, Laville M. Mesurer l'insulinosensibilité en pratique clinique. Diabetes Metab 2001; 27: 201-8
35. Wallace TM, Matthews D. The assessment of insulin resistance in man. Diabet Med 2002; 19: 527-34
36. Scheen AJ. L'insulinorésistance : comment l'évaluer en pratique clinique ? Métabolismes Hormones Diabètes Nutrition 2004; 8: 21-7
37. Scheen AJ, Luyckx FH. Les critères de l'insulinorésistance en clinique. Médecine Clinique Endocrinologie & Diabète 2005; No Hors série "Insulinorésistance": 19-26
38. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-10
39. Mather KJ, Hunt AE, Steinberg HO, et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001; 86: 5457-64
40. Albareda M, Rodriguez-Espinosa J, Murugo M, et al. Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 2000; 43: 1507-11
41. Hansen T, Drivsholm T, Urhammer SA, et al. The BIGTT test. A novel test for simultaneous measurement of pancreatic β-cell function, insulin sensitivity, and glucose tolerance. Diabetes Care 2007; 30: 257-62
42. Ferrannini E, Mari A. Beta-cell function and its relation to insulin action in man: a critical appraisal. Diabetologia 2004, 47: 943-56
43. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006; 29: 1130-9
44. Ferrannini E, Gastaldelli A, Miyazaki Y, et al. β-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 2005; 90: 493-500
45. Abdul-Ghani MA, Jenkinson CP, Richardson DK, et al. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 2006; 55: 1430-5